Wockhardt plans to supply Covid-19 vaccines to UK; shares jump 10%

Topics Wockhardt | Coronavirus Vaccine | UK


Pharma major Wockhardt will supply millions of doses of multiple Covid-19 vaccines, including that being developed by AstraZeneca and Oxford University, under a deal with the UK announced on Monday. Shares of the firm jumped 10 per cent after the news.

The firm has reserved fill-and-finish capacity — the final manufacturing step of putting vaccines into vials or syringes and packaging them — as part of the agreement, it said. This is the latest step by the UK to secure supplies and production of Covid-19 vaccines after.

This article is no longer available in our repository.

There could be multiple reasons for this.